Skip to main content
CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.21
+0.06 (0.66%)
Mar 10, 2026, 11:14 AM HKT

CSPC Pharmaceutical Group Revenue

CSPC Pharmaceutical Group had revenue of 6.62B CNY in the quarter ending September 30, 2025, with 3.37% growth. This brings the company's revenue in the last twelve months to 26.21B, down -13.40% year-over-year. In the year 2024, CSPC Pharmaceutical Group had annual revenue of 29.01B, down -7.76%.

Revenue (ttm)
26.21B CNY
Revenue Growth
-13.40%
P/S Ratio
3.65
Revenue / Employee
1.36M CNY
Employees
19,266
Market Cap
104.61B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202429.01B-2.44B-7.76%
Dec 31, 202331.45B513.21M1.66%
Dec 31, 202230.94B3.07B11.02%
Dec 31, 202127.87B2.92B11.73%
Dec 31, 202024.94B2.84B12.84%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeOne Medicines AG 41.59B
Hansoh Pharmaceutical Group Company 14.45B
JD Health International 81.73B
WuXi Biologics 21.98B
Innovent Biologics 12.52B
Sino Biopharmaceutical 33.49B
Akeso 2.75B
Sichuan Kelun-Biotech Biopharmaceutical 1.64B
Revenue Rankings

CSPC Pharmaceutical Group News

More News